Rho GAP p190 Inhibitors

Chemical inhibitors of Rho GAP p190 disrupt its function by targeting various elements of the Rho GTPase signaling pathway. NSC23766 specifically inhibits the interaction between Rho GAP p190 and Rac1, a crucial step needed for Rac1 activation by this GAP. By blocking this binding, NSC23766 hampers Rho GAP p190's ability to regulate Rac1 activity. Similarly, Y-27632 targets the downstream effector ROCK, a Rho-associated protein kinase, which is indirectly regulated by Rho GAP p190. Inhibition of ROCK by Y-27632 therefore diminishes the downstream effects mediated by Rho GAP p190 activation. C3 Exoenzyme takes a different approach by modifying RhoA/B/C through ADP-ribosylation, which leads to their inactivation. Since Rho GAP p190 normally acts on these proteins, their inactivation by C3 Exoenzyme results in a reduced necessity for Rho GAP p190's GAP activity.

Continuing with the theme of indirect inhibition, ML141 and CASIN inhibit Cdc42, a Rho GTPase and a substrate of Rho GAP p190's GAP activity. By preventing the active GTP-bound form of Cdc42, these inhibitors diminish the role of Rho GAP p190. ITX3 and Rhosin focus on the Rac1 and RhoA pathways, respectively. ITX3 inhibits Trio, a guanine nucleotide exchange factor for Rac1, leading to less active Rac1 available for inactivation by Rho GAP p190. Rhosin prevents RhoA from interacting with GEFs, thereby reducing its activation and subsequent need for Rho GAP p190's action. Similarly, ZCL278 blocks Cdc42's interaction with its corresponding GEFs, reducing active Cdc42 levels and, consequently, the functional activity of Rho GAP p190. EHT 1864 destabilizes Rac1, facilitating its conversion to an inactive state and thus reducing Rho GAP p190's role in inactivating Rac1. Secramine A impedes Cdc42's translocation to membranes, which is a prerequisite for its activation by GEFs and subsequent inactivation by Rho GAP p190. Lastly, SMIFH2 targets the formin family of actin nucleators, which are downstream of Rho GTPases, leading to a diminished requirement for Rho GAP p190's regulatory effects on these pathways.